Riskpilot← Back to searchSign inGet full accessMARKEDET LEGESENTER ADMINISTRASJON AS
ASActiveOrg 913150465Skåregata 92, 5528 HaugesundGeneral medical practice activities · NACE 8621Est. 20148 employees
Revenue 2025
NOK 4,3M
+5% vs 2024
EBITDA margin
-0.1%
-104% vs 2024
Equity ratio
3.9%
Financial strength
Net profit 2025
NOK 10K
-74% vs 2024
| Revenue | NOK 4,3M | +5% |
| EBITDA | NOK -5K | -104% |
| Net profit | NOK 10K | -74% |
| Total assets | NOK 868K | +66% |
| Equity | NOK 34K | +41% |
| Employees | 8 | — |
Legal name
MARKEDET LEGESENTER ADMINISTRASJON AS
Org number
913150465
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. mars 2014
Share capital
NOK 120 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utføre laboratorietjenester og administrasjonstjenester, herunder bl.a. Legesekretærfunksjoner og sentralbordtjeneste, for tilknyttet legevirksomhet, og alt hva hermed står i forbindelse.
Address
Skåregata 92, 5528 Haugesund
Phone
+4752722917
Email
post@markedetlegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 688 | 4 028 | 3 850 | 4 075 | 4 263 |
| Staff expenses | −1 821 | −1 853 | −1 733 | −1 870 | −2 160 |
| EBITDA | −53 | 51 | −1 | 121 | −5 |
| Depreciation & amort. | −35 | −33 | −33 | −83 | 14 |
| EBIT | −89 | 18 | −35 | 38 | 10 |
| Net financials | −1 | −0 | −1 | 0 | 0 |
| Profit before tax | −89 | 18 | −36 | 38 | 10 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −89 | 18 | −36 | 38 | 10 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 474 | 458 | 438 | 522 | 868 |
| Equity | 4 | 21 | −14 | 24 | 34 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 470 | 437 | 452 | 498 | 834 |
| Total debt | 470 | 437 | 452 | 498 | 834 |
EBITDA margin
-0.1%
This company
15.8%
Market median
-101% vs market
20212025
Equity ratio
3.9%
This company
38.2%
Market median
-90% vs market
20212025
Return on equity
29.0%
This company
18.4%
Market median
+58% vs market
20212025
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20212025
Asset turnover
4.91×
This company
1.12×
Market median
+338% vs market
20212025
Debt / equity
24.49×
This company
0.62×
Market median
-3850% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CV Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Chairman | 2016 | |
| Board of Directors | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Legekontoret For Sjømenn T. Kvalvik As
MARKEDET LEGESENTER ADMINISTRASJON AS Board members of MARKEDET LEGESENTER ADMINISTRASJON AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Veuskens | Chief Executive Officer | 0 companies |
| Sjur Erik Melkeråen | Chairman | 0 companies |
| Torleiv Kvalvik | Chairman | 0 companies |
| Solfrid Anette Anvedsen | Board of Directors | 0 companies |